A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers
Authors:
- Suresh K. AgarwalSASuresh K. Agarwal
- Robert L. KrielRKRobert L. Kriel
- Richard C. BrundageRBRichard C. Brundage
- Vijay D. IvaturiVIVijay D. Ivaturi
- James C. CloydJCJames C. Cloyd
- 1 August 2013
- journal article
- clinical trial
- Published by Elsevier in Epilepsy Research
- Vol. 105 (3) , 362-367
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pharmacokinetics and Tolerability of Nasal Versus Intravenous Midazolam in Healthy Dutch Volunteers: A Single-Dose, Randomized-Sequence, Open-Label, 2-Period Crossover Pilot StudyClinical Therapeutics, 2011
- Pharmacokinetics and pharmacodynamics of nasally delivered midazolamBritish Journal of Clinical Pharmacology, 2010
- Bioavailability and tolerability of intranasal diazepam in healthy adult volunteersEpilepsy Research, 2009
- A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulationEpilepsy Research, 2009
- Phenomenology of prolonged febrile seizuresNeurology, 2008
- Intranasal midazolam: a comparison of two delivery devices in human volunteersJournal of Pharmacy and Pharmacology, 2006
- Pharmacokinetics and Pharmacodynamics of a New Intranasal Midazolam Formulation in Healthy VolunteersAnesthesia & Analgesia, 2006
- Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteersBritish Journal of Clinical Pharmacology, 2002
- Status EpilepticusNew England Journal of Medicine, 1998
- Absorption of diazepam and lorazepam following intranasal administrationInternational Journal of Pharmaceutics, 1989